216 Jewish Hospital of St. Louis

https://digitalcommons.wustl.edu/bjc_216/1168/thumbnail.jp

Barnes Hospital Bulletin

https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1168/thumbnail.jp

Barnes Hospital Record

https://digitalcommons.wustl.edu/bjc_barnes_record/1168/thumbnail.jp

Spartan Daily September 8, 2010

Volume 135, Issue 5https://scholarworks.sjsu.edu/spartandaily/1168/thumbnail.jp

Foreign Labor Trends: Belize

Foreign Labor Trendsbelize_2002.pdf: 1168 downloads, before Oct. 1, 2020

Central Charge Reduction and Spacetime Statistics in the Fractional Superstring

Fractional superstrings in the tensor-product formulation experience ``internal projections'' which reduce their effective central charges. Simple expressions for the characters of the resulting effective worldsheet theory are found. All states in the effective theory can be consistently assigned definite spacetime statistics. The projection to the effective theory is shown to be described by the action of a dimension-three current in the original tensor-product theory.Comment: 11 pages (LaTeX), CLNS 92/1168, McGill/92-41 (minor typos corrected

H.B. 1168: The Burden of Proving an Affirmative Defense

The burden of proof for an affirmative defense in a criminal prosecution was recently revised by H.B. 1168. The new statute provides that: “Every person accused of an offense is presumed innocent until proven guilty beyond a reasonable doubt, and the burden of proof for all elements of the offense is upon the prosecution. The burden of going forward with the evidence of an affirmative defense, and the burden of proof, by a preponderance of the evidence, for an affirmative defense, is upon the accused.” The purpose of H.B. 1168 was to place the burden of proving an affirmative defense on the accused. This note will discuss the origin and effect of H.B. 1168. The first part will summarize the Ohio law on affirmative defenses. This will be followed by United States Supreme Court decisions and Ohio cases which have discussed the defendant\u27s burden of proof and affirmative defenses. Finally, the constitutionality of H.B. 1168 and its impact on Ohio criminal justice will be examined

Exact detection of direct links in networks of interacting dynamical units

Authors NR, EB-M, CG, and MSB acknowledge the Scottish Universities Physics Alliance (SUPA). EB-M and MSB also acknowledge the Engineering and Physical Science Research Council (EPSRC) project Ref. EP/I032 606/1. ACM and CM acknowledge the LINC project (FP7-PEOPLE-2011-ITN, grant no. 289447). ACM also aknowledges PEDECIBA and CSIC(Uruguay). CM also acknowledges grant FIS2012–37655-C02–01 from the Spanish MCI, grant 2009 SGR 1168, and the ICREA Academia programme from the Generalitat de Catalunya.Peer reviewedPublisher PD

Central Washington University Football Statistics, 1998

https://digitalcommons.cwu.edu/cwu_football/1168/thumbnail.jp

Evidence for the use of ‘‘medical marijuana’’ in psychiatric and neurologic disorders

Introduction: Cannabis is listed as a Schedule I substance under the Controlled Substances Act of 1970, meaning the US federal government defines it as an illegal drug that has high potential for abuse and no established medical use; however, half of the states in the nation have enacted “medical marijuana” (MM) laws. Clinicians must be aware of the evidence for and against the use of MM in their patients who may consider using this substance. Methods: A PubMed database search was performed using the text string: “Cannabis”[Mesh] OR “Marijuana Abuse”[Mesh] OR “Medical Marijuana”[Mesh] OR “Marijuana Smoking”[Mesh] OR “cannabi*” OR “tetrahydrocannabinol.” The search was further limited to randomized clinical trial publications in English on human subjects to identify articles regarding the therapeutic use of phytocannabinoids for psychiatric and neurologic disorders. Commercially available products (ie, dronabinol, nabilone, nabiximols) and synthetic cannabinoids were excluded from the review. Results: Publications were identified that included patients with dementia, multiple sclerosis, Parkinson disease, Huntington disease, schizophrenia, social anxiety disorder, depression, tobacco use disorder, and neuropathic pain. Discussion: There is great variety concerning which medical conditions are approved for treatment with MM for either palliative or therapeutic benefit, depending on the state law. It is important to keep an evidence-based approach in mind, even with substances considered to be illegal under US federal law. Clinicians must weigh risks and benefits of the use of MM in their patients and should ensure that patients have tried other treatment modalities with higher levels of evidence for use when available and appropriate